nach oben

Urolithiasis

Erschienen in:

01.12.2023 | Research

Anti-urolithiatic effect of Cucumis melo L. var inodorous in male rats with kidney stones

verfasst von: Maryam Eidi, Leila Ashjazadeh

Erschienen in: Urolithiasis | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Melon seed extracts have high antioxidant activities and are effective against a variety of diseases, including kidney stones. In kidney stone model rats, the anti-urolithiatic effects of the hydro-ethanolic extract of melon seed and potassium citrate were studied and compared. After urolithiasis induction by ethylene glycol, the extract and potassium citrate were treated orally for 38 days concurrent with ethylene glycol. Then, urine and kidney sampling were done, and the urinary parameter levels were measured. The melon and potassium citrate treatments reduced the kidney index, the levels of urinary calcium and oxalate, calcium oxalate deposit numbers, the score of crystal deposits, histo-pathological damages, and the score of inflammation in the kidney sections, while elevating the urinary pH, magnesium, and citrate levels, and also the expression of the UMOD, spp1, and reg1 genes in the kidney of treated animals. The effect of potassium citrate is the same as the effect of melon in treated animals. So, their effects could be by normalizing urinary parameters, reducing crystal deposits, excreting small deposits from the kidney, reducing the chance of them being retained in the urinary tract, and elevating the expression of the UMOD, spp1, and reg1 genes, which are involved in kidney stone formation.

Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD (2017) Burden of urolithiasis: trends in prevalence, treatments, and costs. Eur Urol Focus 3(1):18–26. https://doi.org/10.1016/j.euf.2017.04.001CrossRefPubMed

Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y (2017) Epidemiology of stone disease across the world. World J Urol 35(9):1301–1320. https://doi.org/10.1007/s00345-017-2008-6CrossRefPubMed

Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31(4):927–949. https://doi.org/10.1016/s0889-8529(02)00030-0CrossRefPubMed

Ratkalkar VN, Kleinman JG (2011) Mechanisms of stone formation. Clin Rev Bone Miner Metab 9:187–197. https://doi.org/10.1007/s12018-011-9104-8CrossRefPubMedPubMedCentral

McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913–1929. https://doi.org/10.1002/jbmr.5650101211CrossRefPubMed

Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99-106. https://doi.org/10.1152/ajprenal.1989.257.1.F99CrossRefPubMed

Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426–430. https://doi.org/10.1073/pnas.89.1.426CrossRefPubMedPubMedCentral

Kahles F, Findeisen HM, Bruemmer D (2014) Osteopontin: a novel regulator at the cross roads of inflammation, obesity and diabetes. Mol Metab 3(4):384–393. https://doi.org/10.1016/j.molmet.2014.03.004CrossRefPubMedPubMedCentral

Reggi MD, Gharib B, Patard L, Stoven V (1998) Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals. J Biol Chem 273(9):4967–4971. https://doi.org/10.1074/jbc.273.9.4967CrossRefPubMed

10.

Raffi HS, Bates JM, Laszik Z, Kumar S (2009) Tamm-Horsfall protein protects against urinary tract infection by Proteus mirabilis. J Urol 2009(181):2332–2338. https://doi.org/10.1016/j.juro.2009.01.014CrossRef

11.

Viswanathan P, Rimer JD, Kolbach AM, Ward MD, Kleinman JG, Wesson JA (2012) Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein. Urol Res 39(4):269–282. https://doi.org/10.1007/s00240-010-0353-7CrossRef

12.

Girelli CR, Accogli R, Coco LD, Angilè F, de Bellis L, Fanizzi FP (2018) H-NMR-based metabolomic profiles of different sweet melon (Cucumis melo L.) Salento varieties: analysis and comparison. Food Res Int 114:81. https://doi.org/10.1016/j.foodres.2018.07.045CrossRefPubMed

13.

Silva MA, Albuquerque TG, Alves RC, Oliveira MBPP, Costa HS (2020) Melon (Cucumis melo L.) by-products: potential food ingredients for novel functional foods? Trends Food Sci Technol 98:181–189. https://doi.org/10.1016/j.tifs.2018.07.005CrossRef

14.

Maietti A, Tedeschi P, Stagno C, Bordiga M, Travaglia F, Locatelli M, Arlorio M, Brandolini V (2012) Analytical traceability of melon (Cucumis melo Var Reticulatus): proximate composition, bioactive compounds, and antioxidant capacity in relation to cultivar, plant physiology state, and seasonal variability. Food Sci 77(6):C646–C652. https://doi.org/10.1111/j.1750-3841.2012.02712.xCrossRef

15.

Srikaran R, Dulanjali SS (2019) Evaluation of in vitro anti-urolithiatic activity of methanolic extract of Cucumis melo seeds on calcium oxalate crystals. Int J Curr Pharm Res 11(1):18–20. https://doi.org/10.22159/ijcpr.2019v11i1.31994CrossRef

16.

Rolim PM, Fidelis GP, Padilha CEA, Santos ES, Rocha HAO, Macedo GR (2018) Phenolic profile and antioxidant activity from peels and seeds of melon (Cucumis melo L. var. reticulatus) and their antiproliferative effect in cancer cells. Braz J Med Biol Res 51(4):e6069. https://doi.org/10.1590/1414-431X20176069CrossRefPubMedPubMedCentral

17.

Wang F, Li H, Zhao H, Zhang Y, Qiu P, Li J, Wang S (2018) Antidiabetic activity and chemical composition of Sanbai melon seed oil. Evid Based Complementary Altern Med. https://doi.org/10.1155/2018/5434156. (ID: 5434156)CrossRef

18.

Yamaguchi S, Wiessner JH, Hasegawa AT, Hung LY, Mandel GS, Mandel NS (2005) Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 12:290–298. https://doi.org/10.1111/j.1442-2042.2005.01038.xCrossRefPubMed

19.

Sikarwar I, Dey YN, Wanjari MM, Sharma A, Gaidhani SN, Jadhav AD (2017) Chenopodium album Linn. leaves prevent ethylene glycol-induced urolithiasis in rats. J Ethnopharmacol 195:275–282. https://doi.org/10.1016/j.jep.2016.11.031CrossRefPubMed

20.

Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K (2005) Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 173(1):271–275. https://doi.org/10.1097/01.ju.0000141311.51003.87CrossRefPubMed

21.

Asselman M, Verhulst A, de Broe ME, Verkoelen CF (2003) Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 14(12):3155–3166. https://doi.org/10.1097/01.asn.0000099380.1895.f7CrossRefPubMed

22.

Corley RA, Meek ME, Carney EW (2005) Mode of action: oxalate crystal-induced renal tubule degeneration and glycolic acid-induced dysmorphogenesis-renal and developmental effects of ethylene glycol. Crit Rev Toxicol 35(8–9):691–702. https://doi.org/10.1080/10408440591007322CrossRefPubMed

23.

Khan SR (1997) Animal models of kidney stone formation: an analysis. World J Urol 15(4):236–243. https://doi.org/10.1007/BF01367661CrossRefPubMed

24.

de Oliveira RB, Coelho EB, Rodrigues MR, de Mello Costa-Machado AR, de Sousa JPB, Berretta AA, Bastos JK (2013) Effect of the Copaifera langsdorffii Desf. leaf extract on the ethylene glycol-induced nephrolithiasis in rats. J Evid Based Complementary Altern Med. https://doi.org/10.1155/2013/131372. (ID 131372)CrossRef

25.

De Yoreo JJ, Qiu SR, Hoyer JR (2006) Molecular modulation of calcium oxalate crystallization. Am J Physiol Renal Physiol 291:F1123-1131. https://doi.org/10.1152/ajprenal.00136.2006CrossRefPubMed

26.

Kleinman JG, Wesson JA, Hughes J (2004) Osteopontin and calcium stone formation. Nephron Physiol 98:43–47. https://doi.org/10.1159/000080263CrossRef

27.

Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL (1998) Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101:1468–1478. https://doi.org/10.1172/JC12131CrossRefPubMedPubMedCentral

28.

Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J (2003) Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139–147. https://doi.org/10.1097/01.asn.0000040593.93815.9dCrossRefPubMed

29.

Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, Ge X, Fiel MI, Nieto N (2012) Osteopontin, an oxidant stress-sensitive cytokine, upregulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling. Hepatology 55(2):594–608. https://doi.org/10.1002/hep.24701CrossRefPubMed

30.

Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75. https://doi.org/10.1007/s10157-004-0292-0CrossRefPubMed

31.

Khan SR, Kok DJ (2004) Modulators of urinary stone formation. Front Biosci. https://doi.org/10.2741/1347CrossRefPubMed

32.

Viswanathan P, Rimer JD, Kolbach AM, Ward MD, Kleinman JG, Wesson JA (2011) Calcium oxalate monohydrate aggregation induced by aggregation of desialylated tamm-horsfall protein. Urol Res 39(4):269–282. https://doi.org/10.1007/s00240-010-0353-7CrossRefPubMedPubMedCentral

33.

El-Achkar TM, Wu XR (2012) Uromodulin in kidney injury: an instigator, bystander, or protector? Am J Kidney Dis 59:452–461. https://doi.org/10.1053/j.ajkd.2011.10.054CrossRefPubMedPubMedCentral

34.

Wu XR, Kong XP, Pellicer A, Kreibich G, Sun TT (2009) Uroplakins in urothelial biology, function, and disease. Kidney Int 75:1153–1165. https://doi.org/10.1038/ki.2009.73CrossRefPubMedPubMedCentral

35.

Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR (2004) Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol 286:F795-802. https://doi.org/10.1152/ajprenal.00357.2003CrossRefPubMed

36.

Getz KA, Campo RA (2017) Trial watch: trends in clinical trial design complexity. Nat Rev Drug Discov 16(5):307. https://doi.org/10.1038/nrd.2017.65CrossRefPubMed

37.

Wu XR (2015) Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall’s plaques. Urolithiasis 43(0 1):65–76. https://doi.org/10.1007/s00240-014-0699-3CrossRefPubMed

38.

Verdier JM, Dussol B, Casanova P, Daudon M, Dupuy P, Berthezène P, Boistelle R, Berland Y, Dagorn JC (1993) La lithostathine rénale: un nouvel inhibiteur protéique de la lithogénèse [Renal lithostathine: a new protein inhibitor of lithogenesis]. Nephrologie 14(6):261–264 (French. PMID: 8145883)PubMed

39.

Eidi M, Bahar M, Eidi A, Pouyan O, Shahmohammadi P (2009) Effect of hydro-alcoholic extract of Cucumis melo L. fruit skin on prevention of calcium oxalate crystallization in vitro. J Med Plants 8(32):46–52

40.

Shobeiriyan F, Ebrahimi M, Eidi M (2021) Effect of Cucumis melo L. seeds extract on renal mRNA levels of interleukin-10 and cyclooxygenase-2 in calcium oxalate urolithiasis rats. Arch Adv IN Biosci 12(2):47–54. https://doi.org/10.22037/aab.v12i2.34477CrossRef

41.

Ibrahim S, Al Haidari R, Mohamed G, Elkhayat E, Moustafa M (2016) Cucumol A: a cytotoxic triterpenoid from Cucumis melo seeds. Rev Bras 26(6):701–704. https://doi.org/10.1016/j.bjp.2016.03.012CrossRef

42.

Zeb A (2016) Phenolic profile and antioxidant activity of melon (Cucumis melo L.) seeds from Pakistan. Foods 5(4):67. https://doi.org/10.3390/foods5040067CrossRefPubMedPubMedCentral

43.

Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189(3):803–811. https://doi.org/10.1016/j.juro.2012.05.078CrossRefPubMed

44.

Ye T, Yang X, Liu H, Lv P, Lu H, Jiang K, Peng E, Ye Z, Chen Z, Tang K (2021) The aflavin protects against oxalate calcium-induced kidney oxidative stress injury via up-regulation of SIRT1. Int J Biol Sci 17(4):1050–1060. https://doi.org/10.7150/ijbs.57160CrossRefPubMedPubMedCentral

Titel: Anti-urolithiatic effect of Cucumis melo L. var inodorous in male rats with kidney stones
verfasst von: Maryam Eidi
Leila Ashjazadeh
Publikationsdatum: 01.12.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Urolithiasis / Ausgabe 1/2023
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-023-01418-6

Neu im Fachgebiet Urologie

24.04.2024 | DGIM 2024 | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Anti-urolithiatic effect of Cucumis melo L. var inodorous in male rats with kidney stones

Abstract

Neu im Fachgebiet Urologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Update Urologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Determining the safety and effectiveness of percutaneous nephrolithotomy and retrograde intrarenal surgery in treating nephrolithiasis in patients with solitary kidneys

Predictive factors for stone management timing after emergency percutaneous nephrostomy drainage in patients with infection and hydronephrosis secondary to ureteral calculi

Association between alcohol and urolithiasis: a mendelian randomization study

Asymptomatic bacteriuria in candidates for active treatment of renal stones: results from an international multicentric study on more than 2600 patients

Urinary supersaturation in a Randomized trial among Individuals with Nephrolithiasis comparing Empiric versus selective therapy (URINE): design and rationale of a clinical trial

Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)

Neu im Fachgebiet Urologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Update Urologie